Acquisition Opportunity Degge Group was acquired by PharmaLex Group in 2017, indicating potential for cross-sell of pharmacovigilance and risk management services within a larger corporate portfolio and access to integrated multinational client bases.

Small Firm Strength As a 11-50 employee firm with revenue between 1M and 10M, Degge represents a mid-market target for scalable safety solutions, training, and technology-enabled pharmacovigilance services that can be packaged for growth through a systems approach.

Pharmacovigilance Focus Core competencies in pharmacovigilance, safety analyses, pharmacoepidemiology, and outcomes research align with PharmaLex’s risk management and regulatory service lines, suggesting high potential for joint offerings and expanded scope of work.

Industry Exposure Degge’s active participation in major conferences and its public listing as an exhibitor demonstrates engagement with industry networks, presenting opportunities for lead generation, partnerships, and targeted events-based outreach.

Technology Stack Utilization of WordPress, OneTrust, and other tech tools indicates readiness for digital marketing collaboration, data governance, and client portal enhancements that can be leveraged to improve service delivery and compliance workflows.